A common theme this earnings season: U.S. business executives are ready to relocate their supply chains if the cost of importing Chinese goods becomes prohibitive.
A strategic technology trend is one with “substantial disruptive potential” that is beginning to break out of an emerging state into broader impact and use, Gartner says.
As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.